SCHEMBL19209484

SCHEMBL19209484

Cc1ccccc1-c1ccc(-c2ccc(OC(F)(F)F)cc2C(=O)O)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.50
IGF2BP2 Q9Y6M1 1/20 0.48
S1PR1 P21453 1/20 0.47
EIF4E P06730 3/20 0.45
PTPN11 Q06124 1/20 0.44
FFAR4 Q5NUL3 4/20 0.43
FFAR1 O14842 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
PDK2 Q15119 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
SCN5A Q14524 1/20 0.40
DHODH Q02127 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19257271 0.85 IGF2BP2 (0.47) IGF2BP2EIF4EPTPN11FFAR4FFAR1
SCHEMBL19257563 0.82 PTPN11 (0.49) IGF2BP2PTPN11FFAR4FFAR1SMN1; SMN2
SCHEMBL27636056 0.79 IGF2BP2 (0.59) IGF2BP2EIF4EFFAR4FFAR1SMN1; SMN2
SCHEMBL3939209 0.79 MCL1 (0.59) MCL1S1PR1PTPN11FFAR4AKR1C2
SCHEMBL20594547 0.78 IGF2BP2 (0.54) IGF2BP2EIF4EPTPN11SMN1; SMN2AKR1C2
SCHEMBL14820473 0.78 EIF4E (0.74) EIF4E
SCHEMBL6676508 0.76 FFAR4 (0.46) FFAR4PDK2PPARGPPARASCN5A
SCHEMBL14126262 0.75 AKR1C3 (0.54) IGF2BP2PTPN11FFAR4AKR1C2PDK2
SCHEMBL5937086 0.75 AKR1C2 (0.52) IGF2BP2EIF4EFFAR4FFAR1SMN1; SMN2
SCHEMBL2326026 0.74 IGF2BP2 (0.49) IGF2BP2FFAR4AKR1C2AKR1C1SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017134146-A1 GPBP INHIBITORS AND USES AND SCALEABLE SYNTHESIS THEREOF FIBROSTATIN, S.L. (ES) 2017-08-10 WO disclosed